Side effects in all analyzed clinical trials Frequency in 1 group UC patients Frequency in 2 group UC patients 95% CI p
Acute infusion reaction 3/56 1/84 0.48-42.18 0,87
Fever 16/56 1/84 3.27-175.89 0.0000043
Serious infectious complications 1/56 5/84 0.04-2.5 0.44
Non-serious infectious complications 7/56 14/84 1.5-23.58 0,66
Malignancy 1/56 4/84 0.05-4.96 0,97
Lethal cases 1/56 1/56    0.1-23.49 0,66
Table 2: Summary analysis of side effects in UC patients, receiving MSC and in control group.